Interestingly, splice variants of the human 15-lipoxygenase 2, the most abundant AA-metabolizing enzyme in prostate cancer, are also catalytically inactive, cytosolic proteins as opposed to their nuclear, enzymatically-active counterpart [40]. This evidence concerns the gene ALOX15B and prostate carcinoma.